IRD vs MSFT: Which Stock is Better?
Side-by-side comparison of Opus Genetics Inc and Microsoft Corp in 2026
IRD
Opus Genetics Inc
$5.71
MSFT
Microsoft Corp
$418.00
Key Metrics Comparison
| Metric | IRD | MSFT | Winner |
|---|---|---|---|
| Market Cap | $396.30M | N/A | IRD |
| P/E Ratio | N/A | 24.57 | MSFT |
| EPS (TTM) | $N/A | $16.00 | MSFT |
| Revenue Growth | -0.1% | 0.2% | MSFT |
| Gross Margin | -117.0% | 68.6% | MSFT |
Analyze IRD
Full quant analysis
Analyze MSFT
Full quant analysis
Analyze Each Stock
Frequently Asked Questions
Is IRD or MSFT a better investment?
Comparing IRD and MSFT: Opus Genetics Inc has a market cap of $396.30M while Microsoft Corp has N/A. Both companies have their strengths - use our detailed metrics comparison to make an informed decision.
What is the difference between IRD and MSFT?
IRD (Opus Genetics Inc) and MSFT (Microsoft Corp) differ in valuation, growth rates, and profitability metrics. Our comparison shows which company leads in each category.
Which stock has better value: IRD or MSFT?
Based on P/E ratios, compare detailed valuation metrics on our dashboard.
Which is growing faster: IRD or MSFT?
MSFT has higher revenue growth at 0.2% vs -0.1% for IRD.
Which company is more profitable: IRD or MSFT?
Microsoft Corp (MSFT) has higher gross margins at 68.6% compared to -117.0% for IRD.
Which is the larger company: IRD or MSFT?
Opus Genetics Inc (IRD) is larger with a market cap of $396.30M compared to N/A for MSFT.
Should I buy IRD or MSFT in 2026?
Both IRD and MSFT have investment merit. IRD trades at $5.71 while MSFT trades at $418.00. Consider your investment goals, risk tolerance, and portfolio diversification before deciding. Our AI analysis tools can provide personalized insights.
What are the key differences between IRD and MSFT stock?
Key differences: Market Cap ($396.30M vs N/A), P/E Ratio (N/A vs 24.6x), Revenue Growth (-0.1% vs 0.2%), Gross Margin (-117.0% vs 68.6%).